Home › Funds › BAKER BROS. ADVISORS LP › MIRM

BAKER BROS. ADVISORS LP position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

BAKER BROS. ADVISORS LP reported holding 445,975 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$52.2M, representing 0.27% of its reported portfolio and ranking #36 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed MIRM holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)445.98K sh
Reported value held$52.21M
Portfolio Weight0.27%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BAKER BROS. ADVISORS LP's MIRM position evolved

BAKER BROS. ADVISORS LP first disclosed a stake in MIRM in Q3 2023 at 190,476 shares (US$6.0M). The position peaked in Q2 2026 at 445,975 shares, worth US$52.2M. Across 8 filings, BAKER BROS. ADVISORS LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 445,975 shares valued at US$52.2M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 190.48K $6.02M New
Q4 2023 190.48K $5.62M Hold
Q1 2024 190.48K $4.78M Hold
Q2 2024 190.48K $6.51M Hold
Q3 2024 190.48K $7.43M Hold
Q4 2024 190.48K $7.88M Hold
Q1 2026 445.98K $41.20M New
Q2 2026 445.98K $52.21M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 61 other funds we track also report a position in MIRM — the largest reported positions include Frazier Life Sciences Management, L.P. (US$899.1M), EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has BAKER BROS. ADVISORS LP held MIRM?

BAKER BROS. ADVISORS LP has disclosed MIRM holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

What is BAKER BROS. ADVISORS LP's current position in MIRM?

As of Q2 2026, BAKER BROS. ADVISORS LP holds 445.98K shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $52.21M, representing 0.27% of its reported portfolio and ranking #36.

Has BAKER BROS. ADVISORS LP been buying or selling MIRM?

In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP held unchanged its position in MIRM. The position peaked in Q2 2026 at 445.98K shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include Frazier Life Sciences Management, L.P., EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.